You are here: Home » Companies » Start-ups » News
Business Standard

This start-up uses artificial intelligence tech for breast cancer screening

Bengaluru-based Niramai uses machine learning and cloud-based screening as well, Tech in Asia

Sumit Chakraberty | Tech In Asia 

This start-up uses artificial intelligence tech for breast cancer screening

One out of two women diagnosed with dies within five years in India. In the US, the fatality is less than one out of five, and in China, one out of four – according to WHO(World Health Organization). Early detection is one of the main reasons for the fall in mortality rates in developed countries.

Shortages of facilities and radiographers coupled with the cost of regular screening, which most people find unaffordable in India, make this a massive problem. has overtaken cervical cancer as the leading cause of death from cancer among women in India.

Bangalore-based startup Niramai is using a combination of machine learning, artificial intelligence, and cloud-based screening to tackle the problem of access and cost of screening. Last week on Tech in Asia, we had a brief description of Niramai in a list of 20 startups in the summer batch of Axilor, an accelerator in Bangalore. Today, Niramai announced seed funding led by Pi Ventures, with participation from Axilor Ventures, 500 Startups, Ankur Capital, and Flipkart co-founder Binny Bansal.

This start-up uses artificial intelligence tech for breast cancer screening
Niramai is an acronym for Non-Invasive Risk Assessment with Machine-learning and It uses a low-cost device that takes high-resolution thermal images which require no radiation. is applied to the images on the cloud to detect This provides an alternative to traditional mammography, which requires expensive equipment and experienced radiographers. The startup claims that its patented Thermalytix technology using thermography can detect tumors five years earlier than mammography or clinical exams.

AI is also preventing unnecessary biopsies from false positives of traditional clinical screening. Niramai’s thermal imagery and cloud-based analytics have the potential to extend the reach of AI for screening around the world, not just in India.


This is an excerpt from the article published on Tech in Asia. You can read the full article here.

RECOMMENDED FOR YOU

This start-up uses artificial intelligence tech for breast cancer screening

Bengaluru-based Niramai uses machine learning and cloud-based screening as well, Tech in Asia

Bengaluru-based Niramai uses machine learning and cloud-based screening as well, Tech in Asia
One out of two women diagnosed with dies within five years in India. In the US, the fatality is less than one out of five, and in China, one out of four – according to WHO(World Health Organization). Early detection is one of the main reasons for the fall in mortality rates in developed countries.

Shortages of facilities and radiographers coupled with the cost of regular screening, which most people find unaffordable in India, make this a massive problem. has overtaken cervical cancer as the leading cause of death from cancer among women in India.

Bangalore-based startup Niramai is using a combination of machine learning, artificial intelligence, and cloud-based screening to tackle the problem of access and cost of screening. Last week on Tech in Asia, we had a brief description of Niramai in a list of 20 startups in the summer batch of Axilor, an accelerator in Bangalore. Today, Niramai announced seed funding led by Pi Ventures, with participation from Axilor Ventures, 500 Startups, Ankur Capital, and Flipkart co-founder Binny Bansal.

This start-up uses artificial intelligence tech for breast cancer screening
Niramai is an acronym for Non-Invasive Risk Assessment with Machine-learning and It uses a low-cost device that takes high-resolution thermal images which require no radiation. is applied to the images on the cloud to detect This provides an alternative to traditional mammography, which requires expensive equipment and experienced radiographers. The startup claims that its patented Thermalytix technology using thermography can detect tumors five years earlier than mammography or clinical exams.

AI is also preventing unnecessary biopsies from false positives of traditional clinical screening. Niramai’s thermal imagery and cloud-based analytics have the potential to extend the reach of AI for screening around the world, not just in India.


This is an excerpt from the article published on Tech in Asia. You can read the full article here.
image
Business Standard
177 22

This start-up uses artificial intelligence tech for breast cancer screening

Bengaluru-based Niramai uses machine learning and cloud-based screening as well, Tech in Asia

One out of two women diagnosed with dies within five years in India. In the US, the fatality is less than one out of five, and in China, one out of four – according to WHO(World Health Organization). Early detection is one of the main reasons for the fall in mortality rates in developed countries.

Shortages of facilities and radiographers coupled with the cost of regular screening, which most people find unaffordable in India, make this a massive problem. has overtaken cervical cancer as the leading cause of death from cancer among women in India.

Bangalore-based startup Niramai is using a combination of machine learning, artificial intelligence, and cloud-based screening to tackle the problem of access and cost of screening. Last week on Tech in Asia, we had a brief description of Niramai in a list of 20 startups in the summer batch of Axilor, an accelerator in Bangalore. Today, Niramai announced seed funding led by Pi Ventures, with participation from Axilor Ventures, 500 Startups, Ankur Capital, and Flipkart co-founder Binny Bansal.

This start-up uses artificial intelligence tech for breast cancer screening
Niramai is an acronym for Non-Invasive Risk Assessment with Machine-learning and It uses a low-cost device that takes high-resolution thermal images which require no radiation. is applied to the images on the cloud to detect This provides an alternative to traditional mammography, which requires expensive equipment and experienced radiographers. The startup claims that its patented Thermalytix technology using thermography can detect tumors five years earlier than mammography or clinical exams.

AI is also preventing unnecessary biopsies from false positives of traditional clinical screening. Niramai’s thermal imagery and cloud-based analytics have the potential to extend the reach of AI for screening around the world, not just in India.


This is an excerpt from the article published on Tech in Asia. You can read the full article here.

image
Business Standard
177 22